EMEA-003137-PIP01-21 - paediatric investigation plan
Ex vivo expanded autologous human keratinocytes containing epidermal stem cells genetically modified with a gamma-retroviral (RV) vector expressing the full-length LAMB3 cDNA (Hologene 5)
PIPHuman
Holostem Terapie Avanzate S.r.l.
+39 3492403930
regulatory@holostem.com